# Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

> **NCT06647238** · NA · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 80 (actual)

## Conditions studied

- Hyperlipidemia
- Coronary Artery Disease

## Interventions

- **OTHER:** Pharmacist Intervention in lipid therapy

## Key facts

- **NCT ID:** NCT06647238
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-05
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-27
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06647238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06647238, "Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06647238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*